Editorial: Advances in the use of EGFR TKIs in the treatment of NSCLC
Front Oncol
.
2024 Oct 31:14:1506160.
doi: 10.3389/fonc.2024.1506160.
eCollection 2024.
Author
Paola Ulivi
1
Affiliation
1
Bioscience Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
PMID:
39544299
PMCID:
PMC11560767
DOI:
10.3389/fonc.2024.1506160
No abstract available
Keywords:
EGFR; TKI; liquid biopsy; lung cancer; resistance.
Publication types
Editorial